Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S2.48
P/E—
Fwd P/E15.94
PEG1.61
52W— – —
RSI—
Target$19.83 (+0.2%)
Beta0.44
Div4.19%
Loading chart…
RSI (14)
Loading patterns…
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 64
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
1Bearish
0Neutral
▲ Double Bottom — Two lows ~$16.62 — bullish reversal confirmed
▲ Double Bottom — Two lows ~$16.74 — bullish reversal confirmed
▲ Bull Flag — Breakout after +8% pole — bullish continuation
▼ Double Top — Two peaks ~$17.84 — bearish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
HOLD
BuyHoldSell
Price Target Range
$19.83
+0.2% upside
Low $18
—
High $23
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Barclays | Equal-Weight | — | ↔ Maintain | 2026-07-21 |
| UBS | Neutral | — | ↔ Maintain | 2026-07-16 |
| Citigroup | Neutral | — | ↔ Maintain | 2026-04-15 |
| Canaccord Genuity | Hold | — | ↔ Maintain | 2026-02-18 |
| Jefferies | Hold | Buy → Hold | ▼ Downgrade | 2026-01-30 |
Barclays
2026-07-21
Equal-Weight
↔ Maintain
UBS
2026-07-16
Neutral
↔ Maintain
Citigroup
2026-04-15
Neutral
↔ Maintain
Canaccord Genuity
2026-02-18
Hold
↔ Maintain
Jefferies
2026-01-30
Hold
(from Buy)
▼ Downgrade
Profitability
Gross Margin
58.60%TTM
Op. Margin
21.62%TTM
ROE
15.70%TTM
Rev. Growth
4.50%YoY
Free Cash Flow
1.86BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
82.97MRQ
Current Ratio
0.98MRQ
Cash
1.08BMRQ
Total Debt
8.80BMRQ
Net Debt
—MRQ
Income
Div. Yield
4.19%TTM
Annual Rate
0.83Fwd
Payout Ratio
98.51%TTM
Dividend History
Payout Ratio (TTM): 98.51%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-05-13 | $0.2080 | 1.21% |
| 2026-02-11 | $0.2080 | 1.14% |
| 2025-11-12 | $0.2080 | 1.28% |
| 2025-08-13 | $0.2080 | 0.99% |
| 2025-05-14 | $0.2050 | 0.93% |
| 2025-02-12 | $0.2050 | 1.03% |
| 2024-11-13 | $0.2050 | 0.94% |
| 2024-08-14 | $0.2050 | 1.04% |
| 2024-05-07 | $0.2000 | 1.08% |
| 2024-02-13 | $0.2000 | 1.14% |
| 2023-11-07 | $0.2000 | 1.13% |
| 2023-08-25 | $0.2000 | 0.98% |
How KVUE Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 38.00B |
| Enterprise Value | 45.72B |
| Trailing P/E | 23.56 |
| Forward P/E | 15.94 |
| PEG Ratio (5yr) | 1.61 |
| Price/Sales (ttm) | 2.48 |
| Price/Book (mrq) | 3.58 |
| EV/Revenue | 2.99 |
| EV/EBITDA | 13.18 |
Share Statistics
| Avg Vol (3m) | 20.47M |
| Shares Outstanding | 1.92B |
| Float | 1.92B |
| % Held by Insiders | 0.05% |
| % Held by Institutions | 94.91% |
| Short Ratio | 2.89 |
| Short % of Float | 3.72% |
Profitability
| Gross Margin | 58.60% |
| Operating Margin (ttm) | 21.62% |
| Profit Margin | 10.61% |
| Return on Assets (ttm) | 7.07% |
| Return on Equity (ttm) | 15.70% |
Income Statement
| Revenue (ttm) | 15.29B |
| Revenue Growth (yoy) | 4.50% |
| Gross Profit (ttm) | 8.96B |
| EBITDA | 3.47B |
| Net Income (ttm) | 1.62B |
| Diluted EPS (ttm) | 0.84 |
| EPS Growth (yoy) | 46.90% |
Balance Sheet
| Total Cash (mrq) | 1.08B |
| Total Debt (mrq) | 8.80B |
| Debt / Equity (mrq) | 82.97 |
| Current Ratio (mrq) | 0.98 |
| Book Value / Share | 5.53 |
| Operating CF (ttm) | 2.26B |
| Free Cash Flow (ttm) | 1.86B |
Trading & Dividends
| Beta (5Y) | 0.44 |
| 50-Day MA | 18.39 |
| 200-Day MA | 17.48 |
| Fwd Dividend Yield | 420.00% |
| Payout Ratio | 98.51% |
Ownership Breakdown
Institutional 94.91%
Insider 0.05%
Public 5.0%
Short Interest
3.72% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in KVUE in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | HOWLETT HEATHER | Chief Financial Officer | Sale at price 18.10 per share. | 3,700 | $66,988 |
| 2026-05-08 | ORLANDO MATTHEW | General Counsel | Sale at price 17.66 per share. | 38,491 | $679,691 |
| 2026-05-01 | CURADO GOMES DE LEMOS LEONARDO | Officer | 24,247 | — | |
| 2026-03-10 | STEVENS MEREDITH | Chief Operating Officer | 5,169 | — | |
| 2026-03-10 | ALVARADO LUANI | Chief Operating Officer | 4,222 | — | |
| 2026-03-10 | LAWSON CARLTON | Officer | 6,157 | — | |
| 2026-03-05 | HOWLETT HEATHER | Officer | 2,722 | — | |
| 2026-03-05 | STEVENS MEREDITH | Chief Operating Officer | 6,178 | — | |
| 2026-03-05 | ALVARADO LUANI | Officer | 4,289 | — | |
| 2026-03-05 | LAWSON CARLTON | Officer | 7,736 | — | |
| 2026-03-03 | HOWLETT HEATHER | Officer | 1,534 | — | |
| 2026-02-13 | HOWLETT HEATHER | Officer | 13,571 | — | |
| 2026-02-13 | STEVENS MEREDITH | Chief Operating Officer | 28,040 | — | |
| 2026-02-13 | ALVARADO LUANI | Officer | 15,942 | — | |
| 2026-02-13 | LAWSON CARLTON | Officer | Conversion of Exercise of derivative security at price 18.66 per share. | 39,426 | $651,365 |
| 2026-02-06 | ALVARADO LUANI | Officer | Conversion of Exercise of derivative security at price 13.76 per share. | 85,534 | $1,176,948 |
| 2025-12-15 | PERRY KIRK L | Chief Executive Officer | 118,561 | — | |
| 2025-12-15 | TILLETT CAROLINE | Officer | 33,922 | — | |
| 2025-12-15 | ORLANDO MATTHEW | General Counsel | 23,920 | — | |
| 2025-12-15 | DYER RUSSELL | Officer | 4,907 | — | |
| 2025-12-12 | SMITH JEFFREY CHAD | Director | Purchase at price 17.37 - 17.43 per share. | 6,377,694 | $110,986,526 |
| 2025-12-01 | STEVENS MEREDITH | Chief Operating Officer | 2,775 | — | |
| 2025-12-01 | TILLETT CAROLINE | Officer | 1,538 | — | |
| 2025-12-01 | ALVARADO LUANI | Officer | 2,020 | — | |
| 2025-12-01 | ORLANDO MATTHEW | General Counsel | 4,378 | — |
HOWLETT HEATHER
Chief Financial Officer
Sale at price 18.10 per share.
2026-06-10
3,700 sh
$66,988
ORLANDO MATTHEW
General Counsel
Sale at price 17.66 per share.
2026-05-08
38,491 sh
$679,691
CURADO GOMES DE LEMOS LEONARDO
Officer
2026-05-01
24,247 sh
—
STEVENS MEREDITH
Chief Operating Officer
2026-03-10
5,169 sh
—
ALVARADO LUANI
Chief Operating Officer
2026-03-10
4,222 sh
—
LAWSON CARLTON
Officer
2026-03-10
6,157 sh
—
HOWLETT HEATHER
Officer
2026-03-05
2,722 sh
—
STEVENS MEREDITH
Chief Operating Officer
2026-03-05
6,178 sh
—
ALVARADO LUANI
Officer
2026-03-05
4,289 sh
—
LAWSON CARLTON
Officer
2026-03-05
7,736 sh
—
HOWLETT HEATHER
Officer
2026-03-03
1,534 sh
—
HOWLETT HEATHER
Officer
2026-02-13
13,571 sh
—
STEVENS MEREDITH
Chief Operating Officer
2026-02-13
28,040 sh
—
ALVARADO LUANI
Officer
2026-02-13
15,942 sh
—
LAWSON CARLTON
Officer
Conversion of Exercise of derivative security at price 18.66 per share.
2026-02-13
39,426 sh
$651,365
ALVARADO LUANI
Officer
Conversion of Exercise of derivative security at price 13.76 per share.
2026-02-06
85,534 sh
$1,176,948
PERRY KIRK L
Chief Executive Officer
2025-12-15
118,561 sh
—
TILLETT CAROLINE
Officer
2025-12-15
33,922 sh
—
ORLANDO MATTHEW
General Counsel
2025-12-15
23,920 sh
—
DYER RUSSELL
Officer
2025-12-15
4,907 sh
—
SMITH JEFFREY CHAD
Director
Purchase at price 17.37 - 17.43 per share.
2025-12-12
6,377,694 sh
$110,986,526
STEVENS MEREDITH
Chief Operating Officer
2025-12-01
2,775 sh
—
TILLETT CAROLINE
Officer
2025-12-01
1,538 sh
—
ALVARADO LUANI
Officer
2025-12-01
2,020 sh
—
ORLANDO MATTHEW
General Counsel
2025-12-01
4,378 sh
—